Browsing by Author Biava, M

Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Third Mission
20081,5-Diphenylpyrrole Derivatives as Antimycobacterial Agents. Probing the Influence on Antimycobacterial Activity of Lipophilic Substituents at the Phenyl RingsBiava, M; PORRETTA G., C; Poce, G; DE LOGU, A; Saddi, M; Meleddu, R; Manetti, Fabrizio ; DE ROSSI, E; Botta, Maurizio Not applicable
2005Antimycobacterial compounds. Optimization of the BM212 structure, the lead compound for a new pyrrole derivative classBiava, M; Porretta, Gc; Poce, G; Deidda, D; Pompei, R; Tafi, Andrea ; Manetti, Fabrizio Not applicable
2000Builiding a pharmacophore model for a novel class of antitubercular compounds.Manetti, Fabrizio ; Corelli, Federico ; Biava, M; Fioravanti, R; Porretta, Gc; Botta, Maurizio Not applicable
2011Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization ApproachBiava, M; PORRETTA G., C; Poce, G; Battilocchio, C; Alfonso, S; DE LOGU, A; Manetti, Fabrizio ; Botta, Maurizio Not applicable
2011Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarrylpyrrole Scaffold as novel anti-inflammatory and analgesic agentsBiava, M; Porretta, Gc; Poce, G; Battilocchio, C; Botta, Maurizio ; Manetti, Fabrizio ; Rovini, M; Cappelli, Andrea ; Sautebin, L; Rossi, A; Pergola, C; Ghelardini, C; Galeotti, N; Makovec, F; Giordani, A; Anzellotti, P; Tacconelli, S; Patrignani, P; Anzini, Maurizio Not applicable
2010Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampinBiava, M; PORRETTA G., C; Poce, G; Battilocchio, C; Alfonso, S; DE LOGU, A; Serra, N; Manetti, Fabrizio ; Botta, Maurizio Not applicable
2013Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents.Tintori, Cristina; Laurenzana, Ilaria; La Rocca, F; Falchi, Federico; Carraro, Fabio; Ruiz, A; Esté, Ja; Kissova, M; Crespan, E; Maga, G; Biava, M; Brullo, C; Schenone, S; Botta, Maurizio Not applicable
2012In Vitro Effects of VA441, a New Selective Cyclooxygenase-2 Inhibitor, on Human Osteoarthritic Chondrocytes exposed to IL-1β.Fioravanti, A; Tinti, Laura; Pascarelli, Na; Capua, Ad; Lamboglia, A; Cappelli, Andrea ; Biava, M; Giordani, A; Niccolini, S; Galeazzi, Mauro; Anzini, Maurizio Not applicable
2013Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography.Baiocco P, 1. 0.; Poce, G; Alfonso, S; Cocozza, M; Porretta, Gc; Colotti, G; Biava, M; Moraca, Francesca; Botta, Maurizio ; Yardley, V; Fiorillo, A; Lantella, A; Malatesta, F; Ilari, A.Not applicable
2012MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212La Rosa, V; Poce, G; Ortiz Canseco, J; Buroni, S; Pasca M., R; Biava, M; Raju R., M; Porretta G., C; Alfonso, S; Battilocchio, C; Javid, B; Sorrentino, F; Ioerger T., R; Sacchettini J., C; Manetti, Fabrizio ; Botta, Maurizio ; De Logu, A; Rubin E., J; De Rossi, E.Not applicable
2007New derivatives of BM212. a class of antimycobacterial compounds based on the pyrrole ring as a scaffoldBiava, M; PORRETTA G., C; Manetti, Fabrizio Not applicable
2013The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunctionMartelli, A; Testai, L; Anzini, Maurizio ; Cappelli, Andrea ; DI CAPUA, Angela; Biava, M; Poce, G; Consalvi, S; Giordani, A; Caselli, G; Rovati, L; Ghelardini, C; Patrignani, P; Sautebin, L; Breschi, M. C; Calderone, V.Not applicable
2013Pharmacophore Assessment Through 3-D QSAR: Evaluation of the Predictive Ability on New Derivatives by the Application on a Series of Antitubercular AgentsFriggeri, L; Ballante, F; Ragno, R; Musmuca, I; De Vita, D; Manetti, Fabrizio ; Biava, M; Scipione, L; Di Santo, R; Costi, R; Feroci, M; Tortorella, S.Not applicable
2008Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agentsBiava, M; PORRETTA G., C; Poce, G; Supino, S; Manetti, Fabrizio ; Forli, S; Botta, Maurizio ; Sautebin, L; Rossi, A; Pergola, C; Ghelardini, C; Norcini, M; Makovec, F; Giordani, A; Anzellotti, P; Cirilli, R; Ferretti, R; Gallinella, B; LA TORRE, F; Anzini, Maurizio ; Patrignani, P.Not applicable